Differences and overlaps between Phd studies in diagnostic microbiology in industrial and academic settings.


Journal

Medical microbiology and immunology
ISSN: 1432-1831
Titre abrégé: Med Microbiol Immunol
Pays: Germany
ID NLM: 0314524

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 27 07 2019
accepted: 14 11 2019
pubmed: 1 12 2019
medline: 11 2 2021
entrez: 1 12 2019
Statut: ppublish

Résumé

Industrial and academic needs for innovation and fundamental research are essential and not widely different. Depending on the industrial setting, research and development (R&D) activities may be more focused on the developmental aspects given the need to ultimately sell useful products. However, one of the biggest differences between academic and industrial R&D will usually be the funding model applied and the priority setting between innovative research and product development. Generalizing, companies usually opt for development using customer- and consumer-derived funds whereas university research is driven by open innovation, mostly funded by taxpayer's money. Obviously, both approaches require scientific rigor and quality, dedication and perseverance and obtaining a PhD degree can be achieved in both settings. The formal differences between the two settings need to be realized and students should make an educated choice prior to the start of PhD-level research activities. Intrinsic differences in scientific approaches between the two categories of employers are not often discussed in great detail. We will here document our experience in this field and provide insights into the need for purely fundamental research, industrial R&D and current mixed models at the level of European funding of research. The field of diagnostics in clinical bacteriology and infectious diseases will serve as a source of reference.

Identifiants

pubmed: 31784890
doi: 10.1007/s00430-019-00643-4
pii: 10.1007/s00430-019-00643-4
pmc: PMC7248035
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

217-223

Subventions

Organisme : Horizon 2020 Framework Programme ()
ID : 675412
Organisme : Horizon 2020 Framework Programme
ID : 765042

Références

mSphere. 2018 May 2;3(3):
pubmed: 29720529
Nature. 2018 Oct;562(7728):611-614
pubmed: 30356203
Lancet Infect Dis. 2019 May;19(5):e172-e178
pubmed: 30551872
Clin Infect Dis. 2014 Jul 15;59(2):272-8
pubmed: 24771332
Front Med (Lausanne). 2019 Jul 03;6:151
pubmed: 31334235
Clin Lab Med. 2019 Sep;39(3):333-344
pubmed: 31383260
Nature. 2019 May;569(7756):S18-S19
pubmed: 31092935
Methods Mol Biol. 2018;1734:13-20
pubmed: 29288442
FEMS Microbiol Lett. 2018 Oct 1;365(19):
pubmed: 30239741
Mayo Clin Proc. 2016 Oct;91(10):1448-1459
pubmed: 27552910

Auteurs

Alex van Belkum (A)

Data Analytics Department, Biomérieux, 3 Route de Port Michaud, 38390, La Balme Les Grottes, France. alex.vanbelkum@biomerieux.com.

Andreu Coello Pelegrin (AC)

Data Analytics Department, Biomérieux, 3 Route de Port Michaud, 38390, La Balme Les Grottes, France.

Rucha Datar (R)

Clinical Unit, Biomérieux, 3 Route de Port Michaud, 38390, La Balme Les Grottes, France.

Manisha Goyal (M)

Data Analytics Department, Biomérieux, 3 Route de Port Michaud, 38390, La Balme Les Grottes, France.

Mattia Palmieri (M)

Data Analytics Department, Biomérieux, 3 Route de Port Michaud, 38390, La Balme Les Grottes, France.

Caroline Mirande (C)

Clinical Unit, Biomérieux, 3 Route de Port Michaud, 38390, La Balme Les Grottes, France.

Valérie Chalansonnet (V)

Clinical Unit, Biomérieux, 3 Route de Port Michaud, 38390, La Balme Les Grottes, France.

Sylvain Orenga (S)

Clinical Unit, Biomérieux, 3 Route de Port Michaud, 38390, La Balme Les Grottes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH